Essex Bio-Technology Limited (HKG:1061)
Hong Kong · Delayed Price · Currency is HKD 3.000
-0.040 (-1.32%)
Jun 1, 2026, 3:59 PM HKT
Essex Bio-Technology Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,701 | 2,138 | 1,667 | 1,413 | 2,401 | 2,848 | |
Market Cap Growth | -30.72% | 28.20% | 17.98% | -41.13% | -15.72% | 15.63% |
Enterprise Value | 1,264 | 1,786 | 1,394 | 1,349 | 2,272 | 2,753 |
Last Close Price | 3.00 | 3.68 | 2.80 | 2.27 | 3.74 | 4.30 |
PE Ratio | 5.35 | 6.72 | 5.43 | 5.13 | 10.65 | 8.23 |
Forward PE | 5.26 | 3.14 | 3.14 | 3.62 | 6.39 | 7.95 |
PS Ratio | 0.94 | 1.18 | 1.00 | 0.81 | 1.82 | 1.74 |
PB Ratio | 0.70 | 0.89 | 0.79 | 0.74 | 1.39 | 1.64 |
P/TBV Ratio | 1.22 | 1.53 | 1.41 | 1.36 | 2.73 | 2.64 |
P/FCF Ratio | 8.56 | 10.75 | 5.15 | 4.44 | 8.19 | 8.93 |
P/OCF Ratio | 5.55 | 6.98 | 4.53 | 4.17 | 6.27 | 6.96 |
PEG Ratio | - | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 |
EV/Sales Ratio | 0.70 | 0.99 | 0.84 | 0.78 | 1.72 | 1.68 |
EV/EBITDA Ratio | 2.67 | 3.82 | 3.48 | 3.35 | 6.76 | 6.57 |
EV/EBIT Ratio | 3.03 | 4.29 | 3.93 | 3.84 | 7.52 | 6.99 |
EV/FCF Ratio | 6.36 | 8.98 | 4.30 | 4.24 | 7.75 | 8.63 |
Debt / Equity Ratio | 0.14 | 0.14 | 0.09 | 0.15 | 0.28 | 0.33 |
Debt / EBITDA Ratio | 0.73 | 0.73 | 0.46 | 0.72 | 1.45 | 1.34 |
Debt / FCF Ratio | 1.75 | 1.75 | 0.58 | 0.92 | 1.67 | 1.77 |
Net Debt / Equity Ratio | -0.18 | -0.18 | -0.18 | -0.11 | -0.03 | -0.06 |
Net Debt / EBITDA Ratio | -0.93 | -0.93 | -0.93 | -0.55 | -0.16 | -0.25 |
Net Debt / FCF Ratio | -2.20 | -2.20 | -1.15 | -0.69 | -0.18 | -0.33 |
Asset Turnover | 0.56 | 0.56 | 0.57 | 0.63 | 0.47 | 0.62 |
Inventory Turnover | 2.08 | 2.08 | 2.14 | 2.07 | 1.34 | 1.83 |
Quick Ratio | 1.92 | 1.92 | 1.62 | 1.37 | 1.81 | 1.95 |
Current Ratio | 2.11 | 2.11 | 1.81 | 1.54 | 2.16 | 2.24 |
Return on Equity (ROE) | 14.02% | 14.02% | 15.18% | 15.06% | 13.01% | 21.89% |
Return on Assets (ROA) | 8.05% | 8.05% | 7.63% | 7.93% | 6.77% | 9.31% |
Return on Invested Capital (ROIC) | 16.18% | 17.16% | 16.81% | 16.55% | 15.82% | 22.89% |
Return on Capital Employed (ROCE) | 15.30% | 15.30% | 15.60% | 17.40% | 14.00% | 18.10% |
Earnings Yield | 18.70% | 14.88% | 18.43% | 19.48% | 9.39% | 12.15% |
FCF Yield | 11.69% | 9.30% | 19.44% | 22.51% | 12.22% | 11.20% |
Dividend Yield | 4.61% | 3.80% | 4.29% | 3.97% | 1.74% | 2.21% |
Payout Ratio | 23.17% | 23.17% | 19.39% | 14.50% | 24.19% | 15.00% |
Buyback Yield / Dilution | 2.63% | 2.63% | 2.24% | 0.62% | 0.43% | 0.21% |
Total Shareholder Return | 7.23% | 6.43% | 6.53% | 4.60% | 2.17% | 2.42% |